Fenotipos de los pacientes respondedores al tratamiento de la apnea obstructiva del sueño mediante los dispositivos de avance mandibular

Introduction: Obstructive sleep apnea (OSA) is a common disorder characterized by episodes of upper airway obstruction, leading to oxygen desaturation, disrupted sleep, and systemic complications. Although continuous positive airway pressure (CPAP) is the standard treatment for OSA, mandibular advan...

Descripción completa

Detalles Bibliográficos
Autor: Camañes-Gonzalvo, Sara
Tipo de recurso: tesis doctoral
Fecha de publicación:2025
País:España
Institución:Universitat de València
Repositorio:RODERIC. Repositorio Institucional de la Universitat de València
OAI Identifier:oai:dnet:roderic_____::06174feae702a207e10f7c130cf3e979
Acceso en línea:https://hdl.handle.net/10550/111048
Access Level:acceso abierto
Palabra clave:obstructive sleep apnea
apnea obstructiva sueño
mandibular advancement devices
dispositivos de avance mandibular
UNESCO::CIENCIAS MÉDICAS
Descripción
Sumario:Introduction: Obstructive sleep apnea (OSA) is a common disorder characterized by episodes of upper airway obstruction, leading to oxygen desaturation, disrupted sleep, and systemic complications. Although continuous positive airway pressure (CPAP) is the standard treatment for OSA, mandibular advancement devices (MADs) present an effective alternative for patients who cannot tolerate CPAP or reject surgery. However, the effectiveness of MADs varies, with a success rate of 60-70%. Identifying phenotypic predictors is crucial for optimizing patient selection and improving therapeutic outcomes. This thesis aims to establish predictive factors to guide clinical decision-making in MAD treatment for OSA. Objectives: The goal of this research is to analyze the phenotypic characteristics that differentiate responders to MAD treatment from non-responders in OSA through four studies: 1. Systematic review and meta-analysis of predictors of MAD efficacy. 2. Analysis of polysomnographic phenotypes and their integration into predictive models. 3. Evaluation of anatomical and physiological characteristics of the airway. 4. Classification of OSA subgroups and assessment of the impact of facial morphology on MAD efficacy. Materials and Methods: - Study 1: A systematic review and meta-analysis were conducted, including studies on MAD efficacy. Clinical, anatomical, and polysomnographic predictors were analyzed, and the quality was assessed using Newcastle-Ottawa, Cochrane, and GRADE tools. - Studies 2 and 3: A prospective analysis of patients treated with MAD over six years was carried out. Logistic regression and CHAID analysis were used to define predictive models based on clinical, anatomical, and polysomnographic variables. - Study 4: A retrospective analysis classified OSA subgroups using K-means clustering. Results: - Study 1: Of 99 studies, 60 were included in the meta-analysis. Responders were younger, with lower BMI, cervical circumference, facial height, hyoid-C3 distance, and minimal cross-sectional area of the airway (CSAmin), along with higher minimum oxygen saturation. Responders also required lower CPAP pressures. - Study 2: In 112 patients, the response rate was higher in positional OSA and lower in REM-dependent OSA or OSA with predominant apneas. Key predictors included T90% and positional OSA in the first definition of response, BMI and apnea-predominant phenotype in the second. CHAID analysis established clinically relevant cutoff values. - Study 3: Predictive models were based on airway length, anterior facial height, and basal T90% (first definition of response); Jarabak index, gonion angle, CSAmin, basal BMI, and basal AHI (second definition). - Study 4: Two subgroups were identified. Subgroup 1, with more severe OSA (higher BMI, T90%, and AHI), vertical facial pattern, and narrower airways, exhibited lower therapeutic success. Facial morphology influenced response, with dolichofacial pattern patients showing the lowest success rate. Conclusions: This thesis identified phenotypic factors that influence the efficacy of MAD treatment in OSA. Predictive models could enhance patient selection and optimize therapeutic outcomes. Future research should validate these models in prospective studies.